Free Nuclear Medicine Exam Questions That Helps Candidates Pass

Comprehensive and Detailed Explanation: Most sestamibi kits require addition of Tc-99m pertechnetate followed by heating in a rolling boiling-water bath (or validated heating block) for a prescribed period (commonly 10 minutes) to complete the exchange reaction that forms the final complex. Incomplete heating results in poor radiochemical purity and excessive soft-tissue and liver uptake. After heating, the vial is cooled and the product is ready for clinical use within its beyond-use time. Technologists must follow the exact instructions for activity, volume, heating duration, and subsequent quality-control testing. Proper preparation is essential for high-quality cardiac and parathyroid imaging.

Comprehensive and Detailed Explanation: Before a patient who has received therapeutic I-131 may be released, the residual dose rate at 1 meter is measured and compared with regulatory or institutional release limits. If the measured rate (or the calculated total effective dose to others) is below the applicable threshold, the patient may be released with written instructions. The survey is documented and retained. Technologists commonly perform or assist with this measurement. Accurate survey technique and proper interpretation of the result are essential for both regulatory compliance and protection of the public.

Comprehensive and Detailed Explanation: At 140 keV in soft tissue (effective Z ≈ 7.5), Compton scattering is the predominant interaction. The photoelectric effect becomes more important at lower energies or in higher-Z materials (bone, contrast agents, lead). Pair production requires photon energies above 1.022 MeV. Photodisintegration occurs only at very high energies. The dominance of Compton scatter explains why scatter correction and energy-window optimization are important in Tc-99m imaging: scattered photons lose energy and can still fall within a wide energy window, degrading contrast. Understanding the relative probabilities of these interactions also guides the design of collimators and the choice of attenuation-correction methods in SPECT and SPECT/CT.

Comprehensive and Detailed Explanation: The usual adult dose of Tc-99m medronate (MDP) or oxidronate (HDP) for a whole-body bone scan is 20–30 mCi (740–1110 MBq), with many laboratories using approximately 25 mCi. Lower activities may be used in pediatric patients (scaled by weight or body-surface area) or when SPECT/CT is the primary examination. Higher activities increase radiation dose without proportional diagnostic benefit. Proper hydration and frequent voiding after injection reduce bladder and radiation dose to the pelvic organs. Imaging is performed 2–4 hours post-injection to allow soft-tissue clearance. Technologists must verify the prescribed activity, assay the dose in a calibrated dose calibrator, and confirm patient identity and pregnancy status before administration. Dose ranges may be adjusted for specific clinical indications or institutional protocols, but 15–30 mCi remains the widely accepted adult range.

Comprehensive and Detailed Explanation: Investigation levels are administrative thresholds (commonly 10–30 % of the regulatory limit) established by the licensee. When a dosimeter reading exceeds an investigation level, the radiation safety officer reviews the worker’s activities, technique, shielding use, and workload to identify the cause and implement corrective actions if needed. This proactive process supports ALARA by addressing elevated exposures before regulatory limits are approached. Investigation levels do not replace regulatory limits and do not automatically result in permanent restriction. Documentation of each investigation is retained as part of the radiation-protection program.